Janux Therapeutics, Inc. · NASDAQ:JANX
Point72 Asset Management, L.P.'s stake in Janux Therapeutics, Inc. fell to 3.30% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Point72 Asset Management, L.P.'s stake in Janux Therapeutics, Inc. fell to 3.30%, 1,993,837 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 1,993,837
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 3.30% | 1,993,837 |
| Point72 Capital Advisors, Inc. | 3.30% | 1,993,837 |
| Steven A. Cohen | 3.30% | 1,993,837 |
Source
Related
- Janux Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Apr 29, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Apr 29, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 12, 2026